579 related articles for article (PubMed ID: 9446949)
1. Organ preservation in carcinoma of the anal canal.
Valentini V; Mantello G; Leone MV; Luzi S; Turriziani A
Rays; 1997; 22(3):447-53. PubMed ID: 9446949
[TBL] [Abstract][Full Text] [Related]
2. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
3. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
4. Cancer of the anal canal and local control.
Valentini V; Mantello G; Luzi S; Macchia G; Manfrida S; Smaniotto D
Rays; 1998; 23(3):586-94. PubMed ID: 9932478
[TBL] [Abstract][Full Text] [Related]
5. Treatment of epidermoid carcinoma of the anal canal.
Greenall MJ; Quan SH; Urmacher C; DeCosse JJ
Surg Gynecol Obstet; 1985 Dec; 161(6):509-17. PubMed ID: 3934775
[TBL] [Abstract][Full Text] [Related]
6. Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.
Ferrigno R; Nakamura RA; Dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV; Filho WJ; Lopes A
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1136-42. PubMed ID: 15752894
[TBL] [Abstract][Full Text] [Related]
7. [Concurrent chemoradiotherapy for squamous cell carcinoma of the anal canal-report of four cases].
Kinjo A; Ogawa K; Iraha S; Tamaki W; Toita T; Kakinohana Y; Samura H; Kinjo I; Nishimaki T; Kuniyoshi Y; Murayama S
Gan To Kagaku Ryoho; 2008 Mar; 35(3):519-22. PubMed ID: 18347409
[TBL] [Abstract][Full Text] [Related]
8. [The anal canal: 2 cycles of radiochemotherapy and boost brachytherapy].
Valentini V; Mantello G; Luzi S; Genovesi D; Smaniotto D; Mantini G; Coco C; Ratto C; Sofo L; Cellini N
Radiol Med; 1997 Apr; 93(4):451-6. PubMed ID: 9244925
[TBL] [Abstract][Full Text] [Related]
9. [Prognosis of epidermoid anal carcinoma regression after conservative treatment].
Vorob'ëv GI; Odariuk TS; Orlova LP; Nechushkin MI; Rybakov EG
Vopr Onkol; 2004; 50(6):663-7. PubMed ID: 15755059
[TBL] [Abstract][Full Text] [Related]
10. [Sphincter-preserving radiotherapy of anal carcinoma].
Thöni AF; Greiner R; Peyer T; Leicht E; Lampret T; Feuz J
Schweiz Med Wochenschr; 1992 Oct; 122(44):1689-93. PubMed ID: 1439687
[TBL] [Abstract][Full Text] [Related]
11. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy of carcinomas of the anal canal. Tenon Hospital experience].
Touboul E; Moureau-Zabotto L; Lerouge D; Pène F; Deniaud-Alexandre E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Schlienger M; Laugier A
Cancer Radiother; 2003 Nov; 7 Suppl 1():91s-99s. PubMed ID: 15124550
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group.
Bonin SR; Pajak TF; Russell AH; Coia LR; Paris KJ; Flam MS; Sauter ER
Cancer; 1999 Mar; 85(6):1226-33. PubMed ID: 10189126
[TBL] [Abstract][Full Text] [Related]
15. [Outcome of simultaneous radiochemotherapy of anal carcinoma].
Fraunholz IB; Adamietz IA; Lorenz M; Staib-Sebler E; Böttcher HD
Zentralbl Chir; 1997; 122(1):39-43. PubMed ID: 9133135
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy followed by radiotherapy in the treatment of anal cancer.
Lee DH; Kim I; Song HH; Jung JY; Kim DY; Lee KW; Kim TY; Heo DS; Bang YJ; Ha SW; Park JG; Kim NK
Oncol Rep; 2003; 10(1):101-4. PubMed ID: 12469152
[TBL] [Abstract][Full Text] [Related]
18. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
Lancet; 1996 Oct; 348(9034):1049-54. PubMed ID: 8874455
[TBL] [Abstract][Full Text] [Related]
19. Management of carcinoma anal canal with combination chemotherapy and concurrent radiotherapy.
Mishra RC; Senapati S; Sai PL
J Indian Med Assoc; 1996 Feb; 94(2):53-4, 57. PubMed ID: 8810177
[TBL] [Abstract][Full Text] [Related]
20. Organ preservation in rectal cancer.
Valentini V; Ziccarelli L; Rosetto ME; Marmiroli L; Coco C
Rays; 1997; 22(3):454-9. PubMed ID: 9446950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
